{"certainAgreement":{"piSponsorEmployee":false,"restrictiveAgreement":false},"limitationsAndCaveats":{"description":"Due to early study closure, patients were followed for less time than was protocol specified to determine the symptomatic myeloma progression free-survival (SMPFS) rate. The protocol specifies 5 years of follow-up, however arm 2 patients were followed until SMPFS or between 4.5 months to 3.5 years."},"pointOfContact":{"email":"mahindra.anuj@scrippshealth.org","organization":"Scripps Health","phone":"858-554-8788","title":"Anuj Mahindra, M.D."}}